Sign Up
OverviewAPI
Several biopharmaceutical companies, including Zentalis Pharmaceuticals and G1 Therapeutics, have granted stock options and awards to new employees under inducement plans, with a focus on cancer treatments and gene therapies. These grants come with specific exercise prices, terms, and vesting schedules, reflecting the companies' commitment to attracting top talent and advancing their innovative products.

Ask a question